Chiorean Diana Maria, Mitranovici Melinda-Ildiko, Toru Havva Serap, Cotoi Titiana Cornelia, Tomuț Alexandru Nicușor, Turdean Sabin Gligore, Cotoi Ovidiu Simion
Department of Pathology, County Clinical Hospital of Targu Mures, 540072 Targu Mures, Romania.
Department of Obstetrics and Gynecology, Emergency County Hospital Hunedoara, 14 Victoriei Street, 331057 Hunedoara, Romania.
Diagnostics (Basel). 2023 Jul 4;13(13):2265. doi: 10.3390/diagnostics13132265.
This comprehensive review explores the genetic contributions to endometriosis and their potential impact on improving diagnostic techniques. The review begins by defining endometriosis and discussing its prevalence, emphasizing the need for a deeper understanding of the genetic basis of the condition. It highlights recent genome-wide association studies (GWAS) that have identified specific genetic variants associated with endometriosis, shedding light on the molecular pathways and mechanisms involved. The review addresses genetic heterogeneity across different populations and ethnicities, emphasizing the importance of considering population-specific markers in diagnostic approaches. It explores the diagnostic implications of genetic insights, including the potential use of genetic markers for precise and early detection, as well as risk prediction. The review also delves into the integration of genetic information with clinical parameters and imaging findings, and the exploration of multi-omics approaches for a comprehensive understanding of endometriosis. It discusses recent studies on genetic and epigenetic biomarkers, their potential as diagnostic tools, and the need for validation in independent cohorts. The review highlights the impact of new genomic technologies, such as next-generation sequencing, in improving diagnostic accuracy and personalized management. It identifies the challenges and future directions in translating genetic findings into diagnostic tools and emphasizes the transformative potential of genetic insights in endometriosis diagnosis. This review provides a roadmap for future research and underscores the significance of genetic insights in improving diagnostic precision and personalized care for individuals with endometriosis.
本综述全面探讨了基因因素对子宫内膜异位症的影响及其对改进诊断技术的潜在作用。综述首先对子宫内膜异位症进行了定义,并讨论了其患病率,强调了深入了解该疾病基因基础的必要性。文中重点介绍了近期全基因组关联研究(GWAS),这些研究已确定了与子宫内膜异位症相关的特定基因变异,从而揭示了其中涉及的分子途径和机制。综述探讨了不同人群和种族之间的基因异质性,强调了在诊断方法中考虑特定人群标志物的重要性。文中探讨了基因研究成果对诊断的意义,包括利用基因标志物进行精准早期检测以及风险预测的可能性。综述还深入研究了基因信息与临床参数及影像学检查结果的整合,以及采用多组学方法全面了解子宫内膜异位症的情况。文中讨论了近期关于基因和表观遗传生物标志物的研究、其作为诊断工具的潜力以及在独立队列中进行验证的必要性。综述强调了新一代测序等新基因组技术在提高诊断准确性和个性化治疗方面的作用。文中确定了将基因研究成果转化为诊断工具所面临的挑战和未来方向,并强调了基因研究成果在子宫内膜异位症诊断中的变革潜力。本综述为未来研究提供了路线图,并强调了基因研究成果在提高子宫内膜异位症患者诊断精准度和个性化医疗方面的重要意义。